Pharmacy and Pharmaceutical Sciences Commons^™

Levetiracetam For Seizure Prophylaxis In Spontaneous Intracerebral Hemorrhage, Alanah Bratley, Krystal Commons, Allycia Natavio

Posters

Characterize the use of levetiracetam for early seizure prophylaxis in patients with sICH

Pharmacist-Provided Educational Intervention And Its Impact On Medical Resident Knowledge And Comfort Level With Continuous Glucose Monitors (Cgms), Chelsea Dezfuli, Sarah Muench, Colleen Lauster

Posters

Continuous glucose monitors (CGMs) have become an integral component of diabetes care

American Diabetes Association now recommends that CGMs be offered to all patients on insulin who can use the device safely

Integrating CGMs into clinical practice can be challenging for several reasons: – Data overload – Cost – Need for education on data interpretation

Safety Evaluation Of Intravenous Heparin Protocol Following Alteplase Treatment In Patients With Suspected Or Confirmed Pulmonary Embolism, Erika Waldsmith, Lisa Hall Zimmerman, Claudia Hanni

Posters

No abstract provided.

Evaluation Of Antimicrobial Prophylaxis In Spine Surgery Within An Enhanced Recovery Program At A Large Community Teaching Hospital, Sabrina Dipietro, Klea Noskey, Richard Zoltowski, Tania Saeed, Sapna Shah

Posters

The risk of surgical site infections post spine surgery is 0% to 18%.1

• American Society of Health System Pharmacists (ASHP) and Enhanced Recovery After Surgery (ERAS) Society guidelines recommend using an agent with activity against the most common surgical site pathogens including Staphylococcus aureus. 2,3

• The preferred agent is cefazolin 2 grams intravenous (IV) (3 grams if patient weighs ≥120 kilograms [kg]) administered 30 minutes prior to skin incision and re-dosed every four hours intraoperatively.2,3

• In the case of a cephalosporin allergy, clindamycin 900 milligrams (mg) IV or vancomycin 15 mg/kg IV are recommended alternatives.2,3

• Due …

Evaluation Of Antibiotic Selection And Duration In Patients With Non-Severe Community Acquired Pneumonia, Emily Reich, Sandra Hartnagle, Jennifer Pilotto, Heidi Klotz, Ryan Herc

Posters

No abstract provided.

Evaluation Of Safety Outcomes Of Two Hydrocortisone Dosing Regimens In Patients In Septic Shock, Alexandra Rola, Joshua Wirtz, Daniel Kalaj, Vasil Rrushi, Megan Cadiz

Posters

• Steroids are used in shock to minimize the impact of shock-induced dysregulation of inflammatory response – Hydrocortisone is preferred for its activity as a glucocorticoid and a mineralocorticoid • Available data on the use of hydrocortisone shows mixed benefit – Data to guide dosing is limited, use of 100 mg IV every 8 hours may have benefit over 50 mg IV every 6 hours • Use of steroids has been associated with potential risks, including gastrointestinal bleeding, hyperglycemia, hypernatremia, superinfection, etc.

Impact Of Continuous Infusion Ketamine As Sedation On Concomitant Opioid And Sedative Requirements In Mechanically Ventilated Covid-19 Patients, Gabrielle R. Bradley, Megan Cadiz, Allycia Natavio

Posters

Characterize the impact of continuous infusion ketamine (CIK) on concomitant opioid and sedative requirements in mechanically ventilated COVID-19 patients

Impact Of Soy-Based Versus Composite Lipid Emulsion (Soybean, Medium Chain Triglycerides, Olive And Fish Oil) In Critically Ill Patients, Sandra Kless, Lisa Hall Zimmerman, Olaf Kroneman

Posters

No abstract provided.

Evaluation Of Vancomycin Based On Risk Factors In Emergent And Critically Ill Patients, Morgan Ragsdale, Lisa Hal Zimmerman, Elizabeth Messana, Derek Volgyi

Conference Presentation Abstracts

INTRODUCTION: Methicillin-resistant Staphylococcus aureus (MRSA) infections are associated with prolonged hospital length of stay and mortality rates up to 20%. Risk factors for MRSA and presumed type of infection often guide vancomycin prescribing. This study evaluated the presence of MRSA risk factors in emergent and critically ill patients who received vancomycin therapy. METHODS: This retrospective study evaluated emergent and critically ill patients who received vancomycin for at least 24 hours for a presumed infection from 1/2020—3/2020. Patients were excluded if vancomycin was administered for surgical prophylaxis. Patients were divided into groups: MRSA Risk (MRSA-R) vs MRSA No Risk (MRSA-NR). MRSA …